A new study has successfully reversed both the biological and behavioral hallmarks of Alzheimer's disease in mouse models. The research found that slowly depleting the presence of a certain enzyme can reverse the formation of amyloid plaques in the brain. Illustrating the tricky path current Alzheimer's research faces, the study was published literally hours after giant pharmaceutical company Merck announced the cancellation of a Phase 3 clinical trial surrounding a drug that targets the exact same enzyme...
Continue Reading New study reverses Alzheimer's in mice, while similar big clinical trial fails

Category: Medical


Alzheimer's Disease


Related Articles:

Scientists unclog genetic brain blockade in mice with Alzheimer's

Excess sugar linked to Alzheimer's in new study

Protein discovery sheds light on brain sediment behind Alzheimer's disease

Alzheimer's blood test promises detection years before symptoms develop

Diabetes drug found to reverse symptoms of memory loss in Alzheimer's mice

Alzheimer's may be prevented by antibody-releasing implant

Who Voted for this Story

Clickiz.com is a social bookmarking place where you can share, find & discuss the best news around on most topics. We focus on hi-tech reviews, gadgets and geekery but we like almost anything that's awesome, appealing and thought-provoking! er6i9ds5mz

Add to Technorati Favorites